The Safety of Plasma-Derived versus Recombinant Concentrates
In this monograph, the author offers his perspective on the risk of infection from recombinant and plasma-derived products.
Transmissible Agents and the Safety of Coagulation Factor Concentrates
This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Russian A multifaceted approach that includes safety measures at every stage of production is needed to minimize the risk of viral transmission by coagulation factor replacement products.